Erratum
Erratum: Increased C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI
An Erratum on
Begic E, Obradovic S, Jankovic S, Romanovic R, Djenic N, Dzudovic B, Jovic Z, Malovic D, Subota V, Stavric M, Ljuca F, Kusljugic Z. Increased High Sensitive C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI. Erciyes Med J. 2020; 42(3): 276-280. doi:10.14744/etd.2020.86429
Correct Title: Increased C-reactive Protein is Associated with Major Adverse Cardiovascular Events after STEMI
The study investigated the effect of C-reactive protein (CRP). It was written in the paper that it was a high-sensitive C-reactive protein (hsCRP). All results should refer to CRP, instead of hsCRP.
The study concluded that the CRP values in patients with STEMI who were treated with pPCI were related to systolic function in the early phase of STEMI, as well as MACE during the first six months of follow-up.